J&J Says It's Wait And See On COVID-19 Vaccine Delay, Outlines Rosier Outlook for 2021

 
• By Jessica Merrill

It will be several days at least before more information is available about the unexpected illness in J&J's Phase III COVID-19 vaccine trial, the firm said during its third quarter financial call.

Canine
J&J and the public are eagerly awaiting more data on a COVID-19 vaccine trial delay • Source: Shutterstock

More from Earnings

More from Business